Migraine Clinical Trials

About DM Clinical Research

DM Clinical Research operates a network of clinical trial sites, functioning as both a site management organization (SMO) and a service provider to sponsors and CROs. Headquartered in Houston with a reported 700+ employees, the company has built an 18+ year track record conducting trials across multiple therapeutic areas. Its business model leverages direct patient recruitment, including an ambassador program, and provides full-service clinical research execution, with a notable involvement in COVID-19 vaccine trials as part of the #HoustonFightsCOVID initiative. The company appears to be a private, revenue-generating services firm in the clinical research sector.

About Boston Clinical Trials

Boston Clinical Trials is a private, revenue-generating clinical research organization (CRO) and site management organization (SMO) based in Roslindale, Massachusetts. Founded in 2008, it has conducted over 300 studies across more than 10 therapeutic areas, primarily focusing on central nervous system disorders, migraines, and other medical specialties. The company's business model is service-based, generating revenue from pharmaceutical and biotech sponsors for patient recruitment, trial execution, and site management. It differentiates itself through patient-centric services like compensation, evening appointments, and a convenient location.

Therapeutic Areas

Other Migraine Drugs